Filing Details
- Accession Number:
- 0001104659-18-041954
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-06-25 09:47:45
- Reporting Period:
- 2018-06-22
- Accepted Time:
- 2018-06-25 09:47:45
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1641640 | Nabriva Therapeutics Plc | NBRV | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1735382 | Jennifer Schranz | 1000 Continental Drive Suite 600 King Of Prussia PA 19406 | Chief Medical Officer | No | Yes | No | No |
Transaction Summary
| Purchased: | 5,500 shares | Avg. Price: $3.73 | Total Value: $20,515.00 |
| Number of Shares After Transactions: | 5,500 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2018-06-22 | 5,500 | $3.73 | 5,500 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
